Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Deloitte
Express Scripts
Cerilliant
Accenture
Citi
Cipla
Colorcon
Farmers Insurance

Generated: June 25, 2018

DrugPatentWatch Database Preview

DEXTROAMPHETAMINE SULFATE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Dextroamphetamine Sulfate patents expire, and when can generic versions of Dextroamphetamine Sulfate launch?

Dextroamphetamine Sulfate is a drug marketed by Able, Actavis Elizabeth, Mayne Pharma, Mylan Pharms Inc, Nesher Pharms, Specgx Llc, Vintage Pharms, Outlook Pharms, Tris Pharma Inc, Ani Pharms Inc, Arbor Pharms Llc, Aurolife Pharma Llc, Avanthi Inc, Barr, Epic Pharma Llc, Halsey, Lannett, Mast Mm, Novel Labs Inc, Purepac Pharm, Sandoz, Sunrise Pharm Inc, Vintage Pharms Llc, and Vitarine. and is included in thirty NDAs.

The generic ingredient in DEXTROAMPHETAMINE SULFATE is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
Summary for DEXTROAMPHETAMINE SULFATE
Drug patent expirations by year for DEXTROAMPHETAMINE SULFATE
Pharmacology for DEXTROAMPHETAMINE SULFATE
Medical Subject Heading (MeSH) Categories for DEXTROAMPHETAMINE SULFATE

US Patents and Regulatory Information for DEXTROAMPHETAMINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 083903-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurolife Pharma Llc DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 202893-001 Jul 31, 2013 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novel Labs Inc DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 204330-001 Mar 16, 2016 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Nesher Pharms DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 040365-001 Oct 31, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Moodys
Federal Trade Commission
Boehringer Ingelheim
Merck
Fuji
Baxter
Dow
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.